Florida-based Catalyst Pharmaceuticals is attempting to show in court that the price of a newly approved treatment for a rare autoimmune disease and pressure from U.S. Sen. Bernie Sanders lead to the approval of a rival treatment.

Executives from the 2015 and 2014 Manny Award winners and finalists share their views on a variety of industry-related topics.

The debate in Washington over drug pricing is getting louder and nastier, and drug marketing is getting caught in the crossfire.